Skip to main content
. Author manuscript; available in PMC: 2019 May 9.
Published in final edited form as: Anesthesiology. 2018 Jun;128(6):1125–1139. doi: 10.1097/ALN.0000000000002156

Table 2.

Comparison of the Hyperinsulinemic Normoglycemia vs. Standard Therapy groups on Secondary Outcomes

Outcomes Hyperinsulinemic Normoglycemia (N = 709) Standard Therapy (N = 730)
N Median (95% CI) N Median (95%CI) HR (99.83%CI)* P-value*
ICU stay (hrs) 0.046b
649 25(24.9, 26.3) 671 27 (25.2, 27.3) 1.13 (0.95, 1.35) 0.025

Hospital stay (days)** 0.07 b
686 8 [6, 12] 713 8 [6, 12] 1.05 (0.89, 1.25) 0.35

N Event (%) N Event (%) RR (99.83%CI)*

Postoperative atrial fibrillation 0.51 b
709 209 (29) 730 235 (32) 0.92 (0.75,1.13) 0.29

Any minor complicationa 0.21 b
709 194(27) 730 227(31) 0.95 (0.87,1.04) 0.13

1-year mortality 0.13 b
653 32 (5) 682 22 (3) 1.52 (0.74,3.11) 0.12
*

Confidence intervals and P values from Cox proportional hazards for ICU stay and Hospital stay, and Cochran-Mantel-Haenszel test for binary outcomes. Confidence intervals adjusted for group sequential design using confidence coefficient of 2.633 for combined sites in order to maintain overall study alpha of 0.05. Significant if P < 0.0085 /6 = 0.0017 using Bonferroni correction.

**

The observed longest hospital stay + 1 day was assigned to patients who died during hospitalization (N = 22).

a

Minor complications include any one of the following: a prolonged requirement for mechanical ventilation (>72 hours), low cardiac index (cardiac index <1.8 l/min/m2 despite adequate fluid replacement and high dose inotropic support for >4 hours), acute kidney injury (increase in creatinine >100%), prolonged hospitalization (>30 days), and all-cause hospital readmission within 30 days).

b

treatment × site P-value.